Metropolis Healthcare Expands with Core Diagnostics Acquisition

Metropolis Healthcare has acquired a 100% stake in Core Diagnostics, a company known for advanced cancer testing. This strategic move aims to enhance Metropolis’ capabilities in specialized diagnostics, particularly in oncology. The acquisition is expected to strengthen their market position and expand their service offerings. Metropolis plans to integrate Core Diagnostics’ advanced technology and expertise to provide better diagnostic solutions for cancer patients. This acquisition aligns with Metropolis’ growth strategy and commitment to offering comprehensive healthcare services. The financial details of the deal were not disclosed.